| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ling Ling, Fangfang Wang, Duonan Y. Beyond neurodegenerative diseases: α-synuclein in erythropoiesis. Hematology (Amsterdam, Netherlands). vol 27. issue 1. 2022-05-27. PMID:35621991. |
an intracellular aggregation of α-syn in dopaminergic neurons is the hallmark of a group of neurodegenerative diseases including parkinson's disease. |
2022-05-27 |
2023-08-13 |
human |
| Kelly B Menees, Jae-Kyung Le. New Insights and Implications of Natural Killer Cells in Parkinson's Disease. Journal of Parkinson's disease. 2022-05-16. PMID:35570499. |
parkinson's disease (pd) is the second most common neurodegenerative disease and is characterized by the loss of dopaminergic neurons in the substantia nigra and the abnormal aggregation and accumulation of the alpha-synuclein (α-syn) protein into lewy bodies. |
2022-05-16 |
2023-08-13 |
mouse |
| Rafaella V Zárate, Sergio Hidalgo, Nicole Navarro, Daniela Molina-Mateo, Duxan Arancibia, Francisca Rojo-Cortés, Carlos Oliva, María Estela Andrés, Pedro Zamorano, Jorge M Campusan. An Early Disturbance in Serotonergic Neurotransmission Contributes to the Onset of Parkinsonian Phenotypes in Cells. vol 11. issue 9. 2022-05-14. PMID:35563850. |
an early disturbance in serotonergic neurotransmission contributes to the onset of parkinsonian phenotypes in parkinson's disease (pd) is a neurodegenerative disease characterized by motor symptoms and dopaminergic cell loss. |
2022-05-14 |
2023-08-13 |
human |
| Deepika Np, Md Habibur Rahman, Sandhya Chipurupalli, Shilpa Tn, Basavan Duraiswam. Emerging Role of Marine Natural Products for the Treatment of Parkinson's Disease. CNS & neurological disorders drug targets. 2022-05-13. PMID:35546747. |
parkinson's disease (pd), known as parkinsonism, is a neurodegenerative disease that mainly affects the elderly and is characterized by an extensive and progressive loss of dopaminergic neurons in the substantia nigra pars compacta (snpc). |
2022-05-13 |
2023-08-13 |
Not clear |
| Kathleen Bai, Ziming Cai, Ibrahim Cherif, Faltas C Compaore, Ayaka Fujikawa, Delilah Hao, Rachel Jia, Sabina C Koziakova, Lenore Liu, Elaine Qiu, Victoria Ramirez, Anna Christensen, Josh Zhang, James Greig, Brendan C MacGillivra. Parkinson's Disease. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 36 Suppl 1. 2022-05-13. PMID:35552291. |
parkinson's disease (pd) is a neurodegenerative disease that involves a progressive loss of dopaminergic neurons within the substantia nigra. |
2022-05-13 |
2023-08-13 |
Not clear |
| Cheng Chen, Yaohua Chen, Tingting Liu, Dan Song, Di Ma, Oumei Chen. Dexmedetomidine Can Enhance PINK1/Parkin-Mediated Mitophagy in MPTP-Induced PD Mice Model by Activating AMPK. Oxidative medicine and cellular longevity. vol 2022. 2022-05-09. PMID:35528513. |
parkinson's disease (pd) is a common neurodegenerative disease characterized by the degeneration of dopaminergic (da) neurons in the substantia nigra (sn). |
2022-05-09 |
2023-08-13 |
mouse |
| Mohammed Nadim Sardoiwala, Soni Jignesh Mohanbhai, Surajit Karmakar, Subhasree Roy Choudhur. Hytrin loaded polydopamine-serotonin nanohybrid induces IDH2 mediated neuroprotective effect to alleviate Parkinson's disease. Materials science & engineering. C, Materials for biological applications. 2022-05-08. PMID:35527145. |
parkinson's disease (pd) is the second most neurodegenerative disease caused due to synucleinopathy leads to the death of dopaminergic and serotonergic neurons. |
2022-05-08 |
2023-08-13 |
Not clear |
| Jianjun Xu, Etsuko Minobe, Masaki Kameyam. Ca Frontiers in cellular neuroscience. vol 16. 2022-05-02. PMID:35496903. |
ca parkinson's disease (pd), a common neurodegenerative disease characterized by motor dysfunction, results from the death of dopaminergic neurons in the substantia nigra pars compacta (snc). |
2022-05-02 |
2023-08-13 |
Not clear |
| Enhui He, You Zhou, Jinping Luo, Shihong Xu, Kui Zhang, Yilin Song, Mixia Wang, Shengwei Xu, Yuchuan Dai, Gucheng Yang, Jingyu Xie, Zhaojie Xu, Wanwan Zhu, Yu Deng, Qi Xu, Xinxia Ca. Sensitive detection of electrophysiology and dopamine vesicular exocytosis of hESC-derived dopaminergic neurons using multifunctional microelectrode array. Biosensors & bioelectronics. vol 209. 2022-04-28. PMID:35483214. |
clinical transplantation of human embryonic stem cells derived dopaminergic neurons (hesc-ddns) is expected to be a potential therapy for treating neurodegenerative diseases. |
2022-04-28 |
2023-08-13 |
human |
| Ilia M Golomidov, Evgenia M Latypova, Elena V Ryabova, Olga I Bolshakova, Artem E Komissarov, Svetlana V Sarantsev. Reduction of the α-synuclein expression promotes slowing down early neuropathology development in the Journal of neurogenetics. 2022-04-25. PMID:35467466. |
reduction of the α-synuclein expression promotes slowing down early neuropathology development in the parkinson's disease (pd) is a neurodegenerative disease characterised by the formation of lewy bodies and progressive loss of dopaminergic (da) neurons in the substantia nigra. |
2022-04-25 |
2023-08-13 |
Not clear |
| Luca Magistrelli, Elena Contaldi, Francesca Vignaroli, Silvia Gallo, Federico Colombatto, Roberto Cantello, Cristoforo Com. Immune Response Modifications in the Genetic Forms of Parkinson's Disease: What Do We Know? International journal of molecular sciences. vol 23. issue 7. 2022-04-12. PMID:35408836. |
parkinson's disease (pd) is a common neurodegenerative disease characterized by loss of dopaminergic neurons in the |
2022-04-12 |
2023-08-13 |
Not clear |
| Katarzyna Kaczyńska, Magdalena Ewa Orłowska, Kryspin Andrzejewsk. Respiratory Abnormalities in Parkinson's Disease: What Do We Know from Studies in Humans and Animal Models? International journal of molecular sciences. vol 23. issue 7. 2022-04-12. PMID:35408858. |
parkinson's disease (pd) is the second most common progressive neurodegenerative disease characterized by movement disorders due to the progressive loss of dopaminergic neurons in the ventrolateral region of the substantia nigra pars compacta (snpc). |
2022-04-12 |
2023-08-13 |
human |
| Jinchuan Zhao, Xin Gao, Liangyou Zhao, Yiqing Wang, Jingbo Zhang, Shumin Li. Effects of Cannabidiol on Parkinson's Disease in a Transgenic Mouse Model by Gut-Brain Metabolic Analysis. Evidence-based complementary and alternative medicine : eCAM. vol 2022. 2022-04-01. PMID:35360659. |
parkinson's disease (pd) is a common neurodegenerative disease characterized by a disorder of the dopaminergic system in the midbrain, causing classical pd motor symptoms. |
2022-04-01 |
2023-08-13 |
mouse |
| Qingyu Ren, Xin Jiang, Yam Nath Paudel, Xin Gao, Daili Gao, Pengyu Zhang, Wenlong Sheng, Xueliang Shang, Kechun Liu, Xiujun Zhang, Meng Ji. Co-treatment with natural HMGB1 inhibitor Glycyrrhizin exerts neuroprotection and reverses Parkinson's disease like pathology in Zebrafish. Journal of ethnopharmacology. 2022-03-31. PMID:35358621. |
parkinson's disease (pd) is the second most devastating age-related neurodegenerative diseases after alzheimer diseases (ad) and is characterized by the loss of dopaminergic (da) neurons in the substantia nigra (sn) and aggregation of α-synuclein (α-syn). |
2022-03-31 |
2023-08-13 |
zebrafish |
| Romgase Sakamula, Teerapong Yata, Wachiryah Thong-As. Nanostructure lipid carriers enhance alpha-mangostin neuroprotective efficacy in mice with rotenone-induced neurodegeneration. Metabolic brain disease. 2022-03-30. PMID:35353275. |
neurodegenerative disease, for instance, parkinson's disease (pd), is associated with substantia nigra dopaminergic neuronal loss with subsequent striatal dopamine reduction, leading to motor deficits. |
2022-03-30 |
2023-08-13 |
mouse |
| Yan-Yan Li, Tian-Tian Zhou, Yi Zhang, Nai-Hong Chen, Yu-He Yua. Distribution of α-Synuclein Aggregation in the Peripheral Tissues. Neurochemical research. 2022-03-29. PMID:35348944. |
parkinson's disease (pd) is a chronic neurodegenerative disease mainly characterized by movement disorders and other non-motor symptoms, including the loss of dopaminergic neurons in the substantia nigra parts. |
2022-03-29 |
2023-08-13 |
Not clear |
| Bo Niklasson, Lars Lindquist, William Klitz, Sten Fredrikson, Roland Morgell, Reza Mohammadi, Netherlands Brain Bank, Yervand Karapetyan, Elisabet Englun. Picornavirus May Be Linked to Parkinson's Disease through Viral Antigen in Dopamine-Containing Neurons of Substantia Nigra. Microorganisms. vol 10. issue 3. 2022-03-26. PMID:35336174. |
parkinson's disease (pd) is a neurodegenerative disease linked with the loss of dopaminergic neurons in the brain region called substantia nigra and caused by unknown pathogenic mechanisms. |
2022-03-26 |
2023-08-13 |
human |
| Jeongah Kim, Inah Park, Sangwon Jang, Mijung Choi, Doyeon Kim, Woong Sun, Youngshik Choe, Ji-Woong Choi, Cheil Moon, Sung Ho Park, Han Kyoung Choe, Kyungjin Ki. Pharmacological Rescue with SR8278, a Circadian Nuclear Receptor REV-ERBα Antagonist as a Therapy for Mood Disorders in Parkinson's Disease. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2022-03-24. PMID:35322351. |
parkinson's disease is a neurodegenerative disease characterized by progressive dopaminergic neuronal loss. |
2022-03-24 |
2023-08-13 |
mouse |
| Lars Tönges, Eun Hae Kwon, Stephan Kleb. Monogenetic Forms of Parkinson's Disease - Bridging the Gap Between Genetics and Biomarkers. Frontiers in aging neuroscience. vol 14. 2022-03-23. PMID:35317530. |
the therapy of neurodegenerative diseases such as parkinson's disease (pd) is still limited to the treatment of symptoms and primarily aimed at compensating for dopaminergic hypofunction. |
2022-03-23 |
2023-08-13 |
Not clear |
| Luca Magistrelli, Elena Contaldi, Cristoforo Com. The Immune System as a Therapeutic Target for Old and New Drugs in Parkinson's Disease. CNS & neurological disorders drug targets. 2022-03-11. PMID:35272601. |
parkinson's disease (pd) is a common neurodegenerative disease characterized by loss of dopaminergic neurons and intraneuronal accumulation of protein aggregates. |
2022-03-11 |
2023-08-13 |
Not clear |